Page last updated: 2024-09-04

bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate and lasofoxifene

bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate has been researched along with lasofoxifene in 1 studies

Compound Research Comparison

Studies
(bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate)
Trials
(bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate)
Recent Studies (post-2010)
(bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate)
Studies
(lasofoxifene)
Trials
(lasofoxifene)
Recent Studies (post-2010) (lasofoxifene)
4012881424

Protein Interaction Comparison

ProteinTaxonomybis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate (IC50)lasofoxifene (IC50)
Estrogen receptorHomo sapiens (human)0.0046
Estrogen receptorRattus norvegicus (Norway rat)0.0112
Estrogen receptor betaRattus norvegicus (Norway rat)0.0112
Estrogen receptor betaHomo sapiens (human)0.0077

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gajdos, C; Jordan, VC1

Reviews

1 review(s) available for bis(4-piperidinophenol)diimidonaphthalene-1,4,5,8-tetracarboxylic acid dibenzosulfoethylate and lasofoxifene

ArticleYear
Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.
    Clinical breast cancer, 2002, Volume: 2, Issue:4

    Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cinnamates; Drug Design; Forecasting; Humans; Molecular Biology; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Toremifene; Treatment Outcome

2002